Journal profile · CARDIAC & CARDIOVASCULAR SYSTEMS

Vessel Plus

ISSN 2574-1209 · OAE Publishing Inc.

Vessel Plus: CAS Zone 4 · Medicine (2026 Xinrui edition); impact factor 1.4 (journal website); fully open access; APC about USD 2,600; review about 8 days (submission to first decision, publisher); 32 articles in 2025; indexed in ESCI and Scopus.

Impact factor1.4From the journal's website, latest value
CAS zoneZone 4 · Medicine2026 Xinrui edition, major category
Review time8 daysPublisher-reported, submission to first decision (includes desk rejections)
APCUSD 2,600Fully open access
Acceptance—No reports yet
Articles per year322025 · OpenAlex count

Scope

Aims, scope and focus

Vessel Plus is published by OAE Publishing Inc. and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Cardiac Valve Diseases and Treatments, Cardiac, Anesthesia and Surgical Outcomes and Aortic Disease and Treatment Approaches, together about 27% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)

The journal is expected to provide an open academic platform for exchange of knowledge, ideas, and latest researches among scholars worldwide to make a truly top-tier journal in this field.The journal focuses on the latest clinical and basic research on the prevention, treatment, prognosis, and mechanisms of diseases of the blood vessels including original articles, commentaries, and expert reviews in molecular biology, physiology, and pathophysiology of the blood vessels. In particular, the journal publishes articles related to the full spectrum of medical and surgical interest in vascular diseases, including but not limited to aneurysm, atherosclerosis, hypertension, stroke, thrombosis, ischemic heart disease, peripheral vascular as well as genetic diseases and others pertinent to vascular pathology.

From the journal's Aims & Scope

Research area (LetPub): CARDIAC & CARDIOVASCULAR SYSTEMS

Editor-in-chief Aijun SunPublisher website

Editorial board by country: 22 in mainland China (about 27%); most named Mainland China 22, United States 19, Italy 10, Australia 5, United Kingdom 3 (83 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Cardiac Valve Diseases and TreatmentsMedicine10.8%
  2. Cardiac, Anesthesia and Surgical OutcomesMedicine8.2%
  3. Aortic Disease and Treatment ApproachesMedicine8%
  4. Coronary Interventions and DiagnosticsMedicine6.9%
  5. Aortic aneurysm repair treatmentsMedicine6.6%
  6. Cardiac and Coronary Surgery TechniquesMedicine6.2%
  7. Cardiac Imaging and DiagnosticsMedicine5%
  8. Atrial Fibrillation Management and OutcomesMedicine4.6%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorCardiac & Cardiovascular SystemsZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor (publisher)
1.4Publisher website ·
CiteScore 2026-06
1.8LetPub ·
CiteScore (publisher)
1.8Publisher website ·
SJR 2026-06
0.29LetPub ·
SNIP 2026-06
0.32LetPub ·
h-index
20OpenAlex ·
i10-index
51OpenAlex ·
2-year mean citedness
1.14OpenAlex ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
98.1%LetPub ·

Volume

Articles per year
30LetPub ·
Articles per year (publisher) 2027
2,027Publisher website ·
Downloads per year (publisher)
597,918Publisher website ·

Articles by year OpenAlex count · 444 in total · the current year is incomplete

YearArticlesOpen accessCitations
202655555
2025323238
20244242104
2023363686
20226666237
20215757317

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Desk decision
8 daysPublisher website ·
Submission to first decision
8 daysPublisher website ·
Peer review
Single anonymous peer reviewPublisher website

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessOpenAlex

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
Publisher websiteUSD 2,600——

Other charges and waivers (author guidelines)

Submission fee
USD 2,600

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Open calls for papers2, by deadline
  1. Topic: The Future of PFO Closure: Beyond Secondary PreventionDeadline
  2. Topic: Exosomes (Extracellular Vesicles; EVs) in Vascular Biology, Cardiovascular Physiology and Medicine: Intercellular Communication and TherapeuticsDeadline
Publisher website
What to prepare9 items from the author guidelines
Abstract
≤ 250 words
Keywords
3–8
Manuscript length
≤ 3,000 words
Reference style
Numbered, in order of citation
Templates
Word
First submission
Free format: the journal's layout is not required
Suggested reviewers
Optional, 3
Graphical abstract
Required
Cover letter
Required
Publisher website · model-extracted, each line checked against the text
Article types accepted7
  1. commentaryThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…Length not stated
  2. meta-analysisThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…Length not stated
  3. mini reviewThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…Length not stated
  4. original articleThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…Length not stated
  5. reviewThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…Length not stated
  6. review articleThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…Length not stated
  7. systematic reviewThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…Length not stated
Publisher website
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
AI use 2.3.3.4 AI and AI-assisted tools Statement

Authors should disclose in their manuscript the use of AI and AI-assisted technologies. Declaring the use of these technologies supports transparency and trust between authors, readers, reviewers, editors and contributors and facilitates compliance with the terms of use of the relevant tool or technology.If the manuscript does not involve this issue, state "Not applicable." in this section.

Source ↗Publisher website ·
Authorship 4. Authorship

Authorship credit of OAE journals should be solely based on substantial contributions to a published study, as specified in the following four criteria:1. Substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data for the work;2. Drafting the work or revising it critically for important intellectual content;3. Final approval of the ve…

Source ↗Publisher website ·
Conflicts of interest 2.3.3.6 Conflicts of Interest

Authors must declare any potential conflicts of interest that may be perceived as inappropriately influencing the representation or interpretation of reported research results. If there are no conflicts of interest, please state "All authors declared that there are no conflicts of interest." in this section. Some authors may be bound by confidentiality agreements. In such cases, in place of itemiz…

Source ↗Publisher website ·
Data availability 2.3.3.3 Availability of Data and Materials

In order to maintain the integrity, transparency and reproducibility of research records, authors should include this section in their manuscripts, detailing where the data supporting their findings can be found. Data can be deposited into data repositories or published as supplementary information in the journal. Authors who cannot share their data should state that the data will not be shared an…

Source ↗Publisher website ·
Publication ethics 2.3.3.7 Ethical Approval and Consent to Participate

Research involving human subjects, human material or human data must be performed in accordance with the Declaration of Helsinki and approved by an appropriate ethics committee. An informed consent to participate in the study should also be obtained from participants, or their parents or legal guardians for children under 16. A statement detailing the name of the ethics committee (including the re…

Source ↗Publisher website ·
License & copyright 1.2 Open Access and Copyright

The journal adopts Gold Open Access publishing model and distributes content under the Creative Commons Attribution 4.0 International License. Copyright is retained by authors. Please make sure that you are well aware of these policies.

Source ↗Publisher website ·
Open access 1.2 Open Access and Copyright

The journal adopts Gold Open Access publishing model and distributes content under the Creative Commons Attribution 4.0 International License. Copyright is retained by authors. Please make sure that you are well aware of these policies.

Source ↗Publisher website ·
Peer review 7.3 AI Use in Peer Review

Confidentiality requirements: Reviewers must not upload manuscripts/materials to AI platforms, as this: 1. Violates OAE’s confidentiality policies2. Risks intellectual property infringement3. May compromise personal data in identifiable content Review integrity standards: Peer review must remain human-driven – AI tools cannot replace critical scholarly judgment.Reviewers must not use AI for manusc…

Source ↗Publisher website ·
Trial registration / reporting guidelines 3.1.5 Trial Registration

OAE requires all authors to register all relevant clinical trials that are reported in manuscripts submitted. OAE follows the World Health Organization (WHO)'s definition of clinical trials: "A clinical trial is any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Interventions i…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
OAE Publishing Inc.
ISSN
2574-1209
Official links

FAQ

Frequently asked questions about Vessel Plus

What CAS zone is Vessel Plus in?

In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Vessel Plus?

The journal's website gives an impact factor of 1.4; this is the journal's own figure, as LetPub lists none for it; CiteScore 1.8, h-index 20.

How long does peer review take at Vessel Plus?

The publisher reports about 8 days (submission to first decision); first decisions include desk rejections. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Vessel Plus?

According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 3–8; Manuscript length: ≤ 3,000 words; Reference style: Numbered, in order of citation; Templates: Word; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional, 3; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of Vessel Plus based?

Of the 83 board members whose country the journal's board page names, 22 (about 27%) are in mainland China; the countries named most often are Mainland China (22), United States (19) and Italy (10). Counted from the institutions listed on the board page; for reference only.

Which databases index Vessel Plus?

According to LetPub and DOAJ records, Vessel Plus is indexed in ESCI and Scopus.

Is Vessel Plus open access, and what is the APC?

Vessel Plus is a fully open-access journal. APC about USD 2,600.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .